3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Cardiac Rupture, Traumatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, K; Ibuki, C; Inami, S; Inui, K; Kamiya, M; Kawanaka, H; Kikuchi, A; Kusama, Y; Miyachi, H; Mizuno, K; Munakata, K; Ohba, T; Seino, Y; Takagi, G; Takahashi, Y; Takano, H; Tanabe, J; Tanaka, K; Yamamoto, E; Yasutake, M | 1 |
1 trial(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
Usefulness of rosuvastatin to prevent periprocedural myocardial injury in patients undergoing elective coronary intervention.
Topics: Acyl Coenzyme A; Aged; Angioplasty, Balloon, Coronary; Dose-Response Relationship, Drug; Elective Surgical Procedures; Female; Fluorobenzenes; Heart Injuries; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Perioperative Care; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2013 |